Substitutions of strontium in mesoporous calcium silicate and their physicochemical and biological properties

Abstract

Calcium silicate (Ca–Si) based bioceramics have been regarded as a potential bioactive materials for bone tissue regeneration. In this study, we have successfully prepared ordered mesoporous strontium (Sr)-substituted CaSiO3 (Sr–CaSiO3) materials by using a triblock copolymer (P123) as a structure-directing agent. The microstructure and porosity of mesoporous Sr–CaSiO3 materials were investigated by X-ray diffraction, scanning electron microscopy, transmission electron microscopy and the N2 adsorption–desorption technique. The substitution of Sr for Ca in mesoporous CaSiO3 did not change the mesoporous structure, but the surface area and pore volume decreased with increasing Sr substitution. The effects of the Sr substitution on the physiochemical and biological properties of mesoporous CaSiO3 materials were evaluated by the ion dissolution, apatite-forming ability, proliferation and alkaline phosphatase (ALP) activity of osteoblast-like MC3T3-E1 cells. The results showed that the increasing Sr substitution decreased the dissolution rate of Ca and Si ions from mesoporous CaSiO3 materials and enhanced the ability to stabilize the pH environment. Mesoporous Sr–CaSiO3 materials have a similar apatite-forming ability to mesoporous CaSiO3 material, and stimulated the proliferation and ALP activity of MC3T3-E1 cells. Furthermore, using gentamicin as a model drug, mesoporous Sr–CaSiO3 materials exhibited a sustained drug release property which could be used in local drug delivery therapy. Furthermore, the drug release rate decreased to some extent with increasing Sr substitution in mesoporous CaSiO3 materials. Therefore, mesoporous Sr–CaSiO3 materials have more potential for application in bone tissue regeneration.